Page last updated: 2024-11-02

pamidronate and Osseous Paget's Disease

pamidronate has been researched along with Osseous Paget's Disease in 175 studies

Research Excerpts

ExcerptRelevanceReference
" We studied patterns of pagetic pain in relation to physical activity, and the effect of coexistent osteoarthritis (OA)/pagetic arthropathy on pain and physical activity before and after treatment with pamidronate."7.72Patterns of pain in Paget's disease of bone and their outcomes on treatment with pamidronate. ( Mehan, R; Miller, H; Swinson, DR; Talwalkar, A; Vasireddy, S, 2003)
"Spinal stenosis is a serious complication of Paget's disease of bone."5.29Pamidronate treatment of the neurologic sequelae of pagetic spinal stenosis. ( Reid, IR; Wallace, E; Wong, J, 1995)
"It was established that in the course of pamidronate infusion therapy BE levels remained constant, whereas the values in serum alkaline phosphatase and pain intensity scores were significantly reduced."5.12The analgesic effect of pamidronate is not caused by the elevation of beta endorphin level in Paget's disease--a controlled pilot study. ( Barna, I; Bender, T; Donáth, J; Gergely, P; Poór, G, 2006)
"Pamidronate has a pharmacologic profile similar to that of etidronate, but pamidronate is more potent and has a longer duration of effect."3.77Pamidronate. ( Kellihan, MJ; Mangino, PD, 1992)
" We studied patterns of pagetic pain in relation to physical activity, and the effect of coexistent osteoarthritis (OA)/pagetic arthropathy on pain and physical activity before and after treatment with pamidronate."3.72Patterns of pain in Paget's disease of bone and their outcomes on treatment with pamidronate. ( Mehan, R; Miller, H; Swinson, DR; Talwalkar, A; Vasireddy, S, 2003)
"Inhibition of skeletal mineralisation is a well-recognized complication of disodium etidronate therapy that was identified in the earliest studies of its use in osteoporosis and Paget's disease."3.70Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease. ( MacGowan, JR; Morris, VH; Pringle, J; Stamp, TC, 2000)
" The hemifacial spasm failed to resolve with intravenous pamidronate."3.69Hemifacial spasm and osteitis deformans. ( Bosley, TM; Ing, EB; Kelepouris, N; Savino, PJ; Sergott, RC, 1995)
"Pamidronate is a bisphosphonate whose short-term biological efficacy in Paget's disease of bone was convincingly established many years ago."2.69Effect of multiple intravenous pamidronate courses in Paget's disease of bone. ( Arlot, M; Meunier, PJ; Thevenon, J; Trombetti, A; Uebelhart, B, 1999)
" Study 1 is a retrospective study of 20 patients with moderate to severe disease who were treated with intravenous (iv) pamidronate (221 +/- 18 mg [SEM]; range 60-360 mg), and after biochemical remission and relapse were retreated with generally larger iv dosage (293 +/- 28 mg; range 180-600 mg)."2.69Paget's disease: acquired resistance to one aminobisphosphonate with retained response to another. ( Bhagat, CI; Criddle, A; Faulkner, DL; Gan, SK; Geelhoed, E; Gutteridge, DH; Kent, GN; Price, RI; Prince, RL; Retallack, RW; Stewart, GO; Stuckey, BG; Vasikaran, S; Ward, LC; Will, RK, 1999)
"An intravenous dosage schedule using pamidronate disodium, based on biochemical severity, was used to treat 71 patients with Paget's disease who had no previous bisphosphonate treatment."2.68Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study. ( Bhagat, CI; Gutteridge, DH; Kent, GN; Nicholson, GC; Price, RI; Prince, RL; Retallack, RW; Stewart, GO; Stuckey, BG; Thompson, RI; Ward, LC, 1996)
"Urinary parameters of bone resorption, free pyridinolines (Pyr) and hydroxyproline (OHP), as well as serum tartrate-resistant acid phosphatase (TRAP) were measured."2.68Pamidronate and biochemical markers of bone turnover. ( Del Campo, MT; Gijón, J; Martínez, ME; Plaza, MA; Torrijos, A, 1997)
" Efficacy on laboratory parameters was greater in the higher dosage group."2.68Pamidronate infusions for the treatment of Paget's disease of bone. ( Ahmed, I; Bon, E; Cantagrel, A; Laroche, M; Mazieres, B; Moulinier, L, 1996)
"Pamidronate treatment for Paget's disease of bone leads to a sustained inhibition of elevated bone turnover."2.68[Bisphosphonate therapy of Paget's disease of bone with pamidronate]. ( Grauer, A; Klar, B; Knaus, J; Scharla, SH; Ziegler, R, 1996)
" Four of the six patients in group 1A achieved normal ALP, whereas ALP remained at an increased level in all of the 10 patients in group 2 whose pretreatment ALP was greater than 1000 U/l, suggesting that a dose-response effect exists."2.67Clinical experience with pamidronate in the treatment of Paget's disease of bone. ( Boyce, BF; Boyle, IT; Gallacher, SJ; Jenkins, A; Patel, U; Ralston, SH, 1991)
"Pamidronate is a second generation bisphosphonate that has been used in Europe for the treatment of Paget's disease of bone for several years."2.67Effects of intravenous pamidronate therapy on Paget's disease of bone. ( Bombassei, GJ; Raisz, LG; Yocono, M, 1994)
" We have evaluated the effectiveness of three dosage regimes of aminohydroxypropylidene bisphosphonate (pamidronate) in 15 patients with extensive Paget's disease who had become refractory to conventional therapy."2.67Pamidronate is effective for Paget's disease of bone refractory to conventional therapy. ( Gunasekera, RD; Wimalawansa, SJ, 1993)
"Paget's disease of bone is a focal skeletal disorder characterized by the formation of structurally abnormal bone, deformity and other complications leading to significant disability and bone pain."2.45The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone. ( De Paola, V; Gennari, L; Martini, G; Merlotti, D; Mossetti, G; Nuti, R; Rendina, D, 2009)
"Paget disease of bone is a disorder of unknown etiology involving disturbances in bone remodeling, typically leading to bone pain and other complications such as skeletal deformities, fractures, hearing loss, and neurologic complications."2.44Paget disease of bone: therapeutic options. ( Silverman, SL, 2008)
" Bisphosphonates restore normal bone turnover and relieve bone pain, but oral formulations may be limited by complicated dosing regimens and poor gastrointestinal absorption."2.44A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg. ( Abelson, A, 2008)
"Inhibitors of bone resorption have been used to suppress bone turnover in the short term, but there is no published data on long-term efficacy."2.42Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy. ( Cundy, T; King, A; Wheadon, L, 2004)
"Pamidronate (APD) is a potent inhibitor of bone resorption that is useful in the management of patients with osteolytic bone metastases from breast cancer or multiple myeloma, tumour-induced hypercalcaemia or Paget's disease of bone."2.40Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone. ( Coukell, AJ; Markham, A, 1998)
" Long term use of low-dose pamidronate in conjunction with conventional antiosteoporotic therapy may halt bone loss in steroid-induced and idiopathic osteoporosis."2.38Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. ( Fitton, A; McTavish, D, 1991)
"Fast bone resorption and formation lead to the development of disorganized bone tissue."1.72Updates on Paget's Disease of Bone. ( Choi, YJ; Chung, YS; Sohn, YB, 2022)
"Pamidronate treatment with vitamin D sufficiency can be effective therapy for the skeletal disease caused by the OPG deficiency form of JPD."1.39Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation. ( Karamizadeh, Z; McAlister, WH; Mumm, S; Nasirabadi, S; Saki, F; Whyte, MP, 2013)
"Hypercalcemia is rare and when it is diagnosed, primary hyperparathyroidism should be ruled out."1.35[Paget's disease and hypercalcemia: coincidence or causal relationship?]. ( Altman, A; Green, I, 2009)
"Oral pamidronate was added after 11 months of i."1.32Chronic idiopathic hyperphosphatasia: normalization of bone turnover with cyclical intravenous pamidronate therapy. ( Alvarez, V; Casco, C; Mautalen, C; Rubinstein, M; Tau, C, 2004)
"Pamidronate treatment (60 mg/day for 3 days) was repeated in patients without evidence of PDB remission at day 120."1.32Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates. ( Mossetti, G; Nunziata, V; Rendina, D; Sorrentino, M; Viceconti, R, 2004)
"Conversely, in Paget's disease and prostate cancer-induced bone metastases, conditions characterized by focal increased bone turnover, alpha L CTX levels were more elevated than those of age-related CTX forms, resulting in increased ratios between native and age-modified CTX."1.32Investigation of bone disease using isomerized and racemized fragments of type I collagen. ( Body, JJ; Christgau, S; Christiansen, C; Cloos, PA; Delmas, P; Engsig, M; Fledelius, C; Garnero, P, 2003)
"pamidronate was given for 6 months."1.31[Fibrous dysplasia: differential diagnosis from Paget's disease]. ( Heilmann, P; Kasperk, Ch; Nawroth, P; Schulz, A; Wagner, P, 2002)
"The various features of carcinoid tumors metastasizing to the skeleton are briefly reviewed."1.31Case of an ivory vertebra. ( Ball, DW; Basaria, S; Belzberg, AJ; McCarthy, EF, 2000)
"Pamidronate treatment did not influence the concentration of beta2-microglobulin and assessment of beta2-microglobulin in Paget's disease bone is no asset."1.30[Is beta 2-microglobulin a marker of bone remodeling in Paget's disease of bone?]. ( Wilczek, H, 1997)
"In all 24 patients studied, bone resorption (measured by urinary hydroxyproline/creatinine ratio, OHP/Cr) fell sharply on treatment, from 0."1.29Long-term elevation of 1,25-dihydroxyvitamin D after short-term intravenous administration of pamidronate (aminohydroxypropylidene bisphosphonate, APD) in Paget's disease of bone. ( Devlin, RD; Fenton, AJ; Grill, V; Gutteridge, DH; Kent, GN; Prince, RL; Retallack, RW; Worth, GK, 1994)
"Pamidronate treatment in patients with Paget's disease of bone is effective and safe."1.29[Paget's disease of bone and treatment with pamidronate]. ( Stĕpán, J; Wilczek, H, 1993)
"Paget's disease of bone is a localized progressive disease, characterized by increased bone remodeling, bone hypertrophy, and abnormal bone structure, leading to pain and deformity."1.29Therapeutic strategy in Paget's disease of bone. ( Meunier, PJ; Vignot, E, 1995)
" Although there was no significant difference in response between the lower dosage groups, there was a greater response in patients treated with a higher dose of APD."1.29Single-day intravenous pamidronate in Paget's disease. ( Clifton-Bligh, P; Forman, L; Hooper, MJ; Lang, FV; Marel, GM; McDowall, D; Tancred, J, 1994)
"The rate and degree of suppression of bone resorption were monitored in 6 of the patients similarly treated with intravenous dimethyl-APD at a dose of 4 mg/day for 10 days, by daily measurements of the 24 h urinary excretion of Pyr, Dpyr and OHP."1.29Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone? ( Colwell, A; Eastell, R; Hamdy, NA; Papapoulos, SE; Russell, RG, 1993)
"Spinal stenosis is a serious complication of Paget's disease of bone."1.29Pamidronate treatment of the neurologic sequelae of pagetic spinal stenosis. ( Reid, IR; Wallace, E; Wong, J, 1995)
" This potentially serious drug side-effect does not appear to have been reported previously in patients with Paget's disease."1.29Ototoxicity associated with intravenous bisphosphonate administration. ( Mills, DA; Reid, IR; Wattie, DJ, 1995)
"Treatment with pamidronate normalized serum calcium concentration and induced a complete biochemical remission."1.28Paget's disease with osteolytic lesions: combining medical and surgical treatments. ( Bloem, RM; Brumsen, C; Papapoulos, SE, 1992)
"Pamidronate was well tolerated; femoral neck fractures occurred in 2 subjects with severe local Paget's disease but were unlikely to be due to the drug."1.28Single-dose intravenous pamidronate is effective alternative therapy for Paget's disease refractory to calcitonin. ( Galligan, JP; Jacobi, JM; Khafagi, FA; Mortimer, RH; Perry-Keene, DA; Yap, AS, 1991)
"Several agents are available for treatment of Paget's disease of bone, but their long-term use may be limited by resistance or adverse effects."1.28Successful treatment of resistant Paget's disease of bone with pamidronate. ( Mallette, LE, 1989)
"Its oral use in Paget's disease of bone has proved effective and safe when the drug is administered on a long-term basis."1.27[Paget's disease of bone treated per os with APD in 5 days]. ( Burckhardt, P; Jaeger, P; Thiébaud, D, 1986)
"Eight patients suffered a recurrence after discontinuation of APD."1.27Quantitative bone scintigraphy in Paget's disease treated with APD. ( Bijvoet, OL; Frijlink, WB; Harinck, HI; Pauwels, EK; Vellenga, CJ, 1985)

Research

Studies (175)

TimeframeStudies, this research(%)All Research%
pre-199039 (22.29)18.7374
1990's93 (53.14)18.2507
2000's37 (21.14)29.6817
2010's3 (1.71)24.3611
2020's3 (1.71)2.80

Authors

AuthorsStudies
Choi, YJ1
Sohn, YB1
Chung, YS1
Maatallah, K1
Ben Nessib, D1
Labbène, E1
Ferjani, H1
Bouaziz, M1
Kaffel, D1
Hamdi, W1
Höppner, J1
Steff, K1
Lobert, F1
Heyer, CM1
Hauffa, BP1
Grasemann, C1
Gonc, EN1
Ozon, A1
Buyukyilmaz, G1
Alikasifoglu, A1
Simsek, OP1
Kandemir, N1
Whyte, MP2
Tau, C2
McAlister, WH2
Zhang, X1
Novack, DV1
Preliasco, V1
Santini-Araujo, E1
Mumm, S2
Silverman, SL1
Seehra, J1
Sloan, P1
Oliver, RJ1
Gennari, L3
Merlotti, D3
Mossetti, G2
Rendina, D2
De Paola, V3
Martini, G3
Nuti, R3
Green, I1
Altman, A1
Saki, F1
Karamizadeh, Z1
Nasirabadi, S1
Isasi, C1
Sanz, J1
Hijós, M1
Vaquero, M1
Saucedo, G1
Andreu, JL1
Cloos, PA1
Fledelius, C2
Christgau, S1
Christiansen, C3
Engsig, M1
Delmas, P1
Body, JJ1
Garnero, P3
Wagner, P1
Heilmann, P1
Schulz, A1
Nawroth, P1
Kasperk, Ch1
Sprecher, S1
Steinberg, R1
Lichtenstein, D1
Witt, KM1
Barginear, M1
Montagnani, A1
Gonnelli, S1
Cepollaro, C1
Campagna, MS1
Franci, MB2
Pacini, S1
Gennari, C1
Gutteridge, DH12
Retallack, RW10
Ward, LC7
Price, RI7
Stewart, GO8
Stuckey, BG9
Prince, RL10
Kent, GN11
Bhagat, CI9
Thompson, RI3
Nicholson, GC4
Naylor, KE1
Jackson, B1
Eastell, R2
Joshua, F1
Epstein, M1
Major, G1
Donáth, J2
Krasznai, M1
Fornet, B1
Gergely, P2
Poór, G2
Vasireddy, S1
Talwalkar, A1
Miller, H1
Mehan, R1
Swinson, DR1
Walsh, JP1
Will, RK3
Criddle, RA1
Dhaliwal, SS2
Drury, PJ1
Vasikaran, S2
Cundy, T3
Wheadon, L1
King, A2
Viceconti, R1
Sorrentino, M1
Nunziata, V1
Mautalen, C5
Casco, C2
Alvarez, V1
Rubinstein, M1
Crisp, AJ5
Tran, HA1
Brixen, KT1
Abrahamsen, B1
Kassem, MS1
Mosekilde, L1
Carter, G1
Goss, AN1
Doecke, C1
Murdin, L1
Yeoh, LH1
Orcel, P1
Rousière, M1
Bender, T1
Barna, I1
Salvadori, S1
Campagna, S1
Avanzati, A2
Valleggi, F2
Bhatt, K1
Balakrishnan, C1
Mangat, G1
Bajan, K1
Ashavaid, T1
Joshi, VR1
Griz, L1
Colares, V1
Bandeira, F1
Papapoulos, SE9
Eekhoff, EM1
Zwinderman, AH2
Abelson, A1
Gueiros, LA1
Lopes, MA1
Leão, JC1
Bijvoet, OL13
Reitsma, PH2
Frijlink, WB5
Mautalen, CA4
Fraser, TR2
Ibbertson, HK3
Holdaway, IM2
Rutland, M1
Dodd, G1
Wattie, DJ2
Jie, K1
van der Linden, H1
Meijer, CJ1
Mulder, H2
van Paassen, HC1
te Velde, J1
de Vries, E1
van der Wey, JP1
Fromm, GA1
Plantalech, L1
González, D4
Nagant de Deuxchaisnes, C1
Rombouts-Lindemans, C1
Huaux, JP1
Devogelaer, JP1
Malghem, J2
Maldague, B2
Withofs, H1
Meersseman, F1
Heynen, G1
Delwaide, P1
Franchimont, P1
Adami, S1
O'Riordan, JL2
Clemens, TL1
van Breukelen, FJ1
Sleeboom, HP1
van Oosterom, AT1
Patel, S4
Pearson, D2
Hosking, DJ6
Lioté, F2
Boval-Boizard, B1
Fritz, P2
Kuntz, D3
Mazières, B3
Macro, M1
Bouvard, G1
Le Gangneux, E1
Colin, T1
Loyau, G1
Rutland, MD1
Gineyts, E1
Arbault, P1
Delmas, PD2
Reid, IR3
Mills, DA1
Wallace, E1
Wong, J1
Coupland, CA1
Stone, MD4
De, S1
Meyer, P1
Perrot, S1
Mortier, E1
Renoux, M1
Job-Deslandre, C1
Menkès, CJ2
Siris, ES2
Roldán, EJ2
Chakravarty, K2
Merry, P2
Scott, DG2
Ing, EB1
Savino, PJ1
Bosley, TM1
Sergott, RC1
Kelepouris, N1
Adamson, BB2
Gallacher, SJ5
Byars, J2
Ralston, SH4
Boyle, IT5
Boyce, BF3
Anderson, DC7
Richardson, PC3
King, AR2
Bombassei, GJ1
Yocono, M1
Raisz, LG1
Vega, E2
Pérez Lloret, A1
Ghose, K1
Waterworth, R1
Trolove, P1
Highton, J1
Sharp, CA2
Worsfold, M2
Rowlands, PR2
Davie, MW3
Wimalawansa, SJ2
Brown, JK1
Freemont, AJ1
Hollis, S2
Denton, J1
Buckler, HM5
Hargreaves, S1
Cantrill, JA4
Hooper, MJ1
Clifton-Bligh, P1
Marel, GM1
Lang, FV1
Tancred, J1
McDowall, D1
Forman, L1
Thiebaud, D6
Portmann, L2
Burckhardt, P6
Haddaway, MJ1
Watts, RA2
Skingle, S1
Bhambani, M1
Pountain, G2
Grauer, A3
Klar, B2
Scharla, SH3
Zieglar, R1
Prince, RI1
Macarol, V1
Fraunfelder, FT1
Thomas, DW1
Shepherd, JP1
Devlin, RD1
Fenton, AJ2
Grill, V1
Worth, GK2
Ryan, PJ3
Fogelman, I3
Pepersack, T1
Karmali, R1
Gillet, C1
François, D1
Fuss, M1
Skingle, SJ1
Bhambhani, MM1
Hamdy, NA1
Colwell, A1
Russell, RG1
Gordon, MT1
Bell, SC1
Mee, AP1
Mercer, S1
Carter, SD1
Sharpe, PT1
Gunasekera, RD1
Coupland, C1
Cormier, C1
Hilliquin, P1
Wilczek, H2
Stĕpán, J1
Hankey, DP1
Hughes, AE1
Mollan, RA1
Nicholas, RM1
Schweitzer, DH1
Vermeij, P3
Johnston, CA1
Staehelin-Bosshard, A2
Meunier, PJ2
Vignot, E1
Constable, IJ1
Wattie, D2
Knaus, J1
Ziegler, R2
Randall, AG1
Garcia-Webb, P1
Pearce, DJ1
Stewart, G1
Stuckey, B1
Ward, L2
Ahmed, I1
Moulinier, L1
Bon, E1
Cantagrel, A1
Laroche, M2
Bonde, M1
Qvist, P1
Ismail, AA1
Fox, P1
Stamp, TC2
Dhillon, V1
MacGregor, A1
Martínez, ME1
Del Campo, MT1
Plaza, MA1
Torrijos, A1
Gijón, J1
Kobayashi, H1
Shigeno, C1
Sakahara, H1
Yamamoto, T1
Hosono, M1
Fujimoto, R1
Konishi, J1
Coukell, AJ1
Markham, A1
Pastrana, M1
Bagur, A1
Arce, G1
Rosano, TG1
Peaston, RT1
Bone, HG1
Woitge, HW1
Francis, RM1
Seibel, MJ1
Broyles, DL1
Nielsen, RG1
Bussett, EM1
Lu, WD1
Mizrahi, IA1
Nunnelly, PA1
Ngo, TA1
Noell, J1
Christenson, RH1
Kress, BC1
Mercer, SJ1
Davison, CE1
Anderson, DG1
Gburek, Z1
Rybicki, A1
Selby, PL1
Delpech, B1
Bernard, J1
Constantin, A1
Criddle, A1
Faulkner, DL1
Geelhoed, E1
Gan, SK1
Trombetti, A1
Arlot, M1
Thevenon, J1
Uebelhart, B1
MacGowan, JR1
Pringle, J1
Morris, VH1
Basaria, S1
McCarthy, EF1
Belzberg, AJ1
Ball, DW1
Lim, EM1
Griffith, K1
Parker, C1
Thorpe, S1
Vincent, RM1
Mikosch, P1
Pietschmann, P1
Kainberger, F1
Gallowitsch, HJ1
Lind, P1
Sherry, M1
Gibson, T2
Kellihan, MJ1
Mangino, PD1
Cassinelli, HR1
Heinrich, JJ1
Miglietta, A1
Bergada, C1
Brumsen, C1
Bloem, RM1
Foley-Nolan, D1
Daly, MJ1
Williams, D1
Wasti, A1
Martin, M1
Fitton, A1
McTavish, D1
Patel, U2
Jenkins, A1
García-Vadillo, JA1
Díaz-González, F1
García de Vicuña, R1
Gómez-Pan, A1
Yap, AS1
Mortimer, RH1
Jacobi, JM1
Galligan, JP1
Perry-Keene, DA1
Khafagi, FA1
Fraser, WD1
Logue, FC1
O'Reilly, DS1
Beastall, GH1
Watson, IG1
Barry-Walsh, C1
Hawthorne, AB1
Kerr, D1
Webster, G1
McKillop, JH1
Miravet, L1
Ryan, WG1
Mallette, LE1
Rapado, A1
Palacios, MC1
Yagüe, M1
Torres, R1
de la Piedra, C1
Jaeger, P4
Jacquet, AF2
Daley-Yates, PT1
Gifford, LA1
Hoggarth, CR1
Drake, S1
Massie, JD1
Postlethwaite, AE1
Palmieri, GM1
Hoekman, K1
Löwik, CW1
Harinck, HI5
Blanksma, HJ2
Dahlinghaus-Nienhuys, PJ1
Dodd, GW1
Moolenaar, AJ1
Anderson, D1
Cantrill, JC1
Stutzmann, JJ1
Petrovic, AG1
Fleisch, H1
O'Driscoll, JB1
Cantrill, J1
Brown, JD1
Gobelet, C1
Ghiringhelli, G2
Frolich, M1
Mudde, AH1
vd Berg, H1
Gleed, JH1
Fraher, LJ1
Vellenga, CJ2
Mulder, JD1
Pauwels, EK1
Dewis, P1
Prasad, BK1
Willets, S1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer[NCT00264420]Phase 14 participants (Actual)Interventional2005-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

17 reviews available for pamidronate and Osseous Paget's Disease

ArticleYear
Paget's Disease of Bone in Patients under 40 Years: Two case reports and review of the literature.
    Sultan Qaboos University medical journal, 2021, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Adult; Alkaline Phosphatase; Female; Humans; Magnetic Resonance Imaging; Male; Ostei

2021
Paget disease of bone: therapeutic options.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2008, Volume: 14, Issue:5

    Topics: Alendronate; Alkaline Phosphatase; Anti-Inflammatory Agents; Diphosphonates; Etidronic Acid; Humans;

2008
The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.
    Mini reviews in medicinal chemistry, 2009, Volume: 9, Issue:9

    Topics: Animals; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Injections, Intraveno

2009
Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2004, Volume: 19, Issue:5

    Topics: Alkaline Phosphatase; Audiometry, Pure-Tone; Biomarkers; Biopsy; Bone Conduction; Bone Density; Bone

2004
[Pharmacological treatment of osteitis deformans (Paget's bone disease)].
    Ugeskrift for laeger, 2005, Feb-28, Volume: 167, Issue:9

    Topics: Alendronate; Analgesics, Non-Narcotic; Antimetabolites; Calcitonin; Clodronic Acid; Diphosphonates;

2005
[Paget's disease and its therapeutic management].
    Presse medicale (Paris, France : 1983), 2005, Apr-23, Volume: 34, Issue:8

    Topics: Administration, Oral; Alkaline Phosphatase; Biomarkers; Diphosphonates; Etidronic Acid; Follow-Up St

2005
[Treatment of Paget's disease of bone: importance of the zoledronic acid].
    Arquivos brasileiros de endocrinologia e metabologia, 2006, Volume: 50, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Resorption; Calcitonin; Dipho

2006
Acquired resistance to bisphosphonates in Paget's disease of bone.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2006, Volume: 21 Suppl 2

    Topics: Diphosphonates; Drug Resistance; Humans; Osteitis Deformans; Pamidronate

2006
A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Current medical research and opinion, 2008, Volume: 24, Issue:3

    Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Disease Progression; Etidronic Acid; Humans;

2008
Paget's disease of bone: current concepts in pathogenesis and treatment.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1994, Volume: 23, Issue:1

    Topics: Cell Transformation, Neoplastic; Diphosphonates; Humans; Osteitis Deformans; Pamidronate; Radionucli

1994
Perspectives: a practical guide to the use of pamidronate in the treatment of Paget's disease.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1994, Volume: 9, Issue:3

    Topics: Diphosphonates; Drug Administration Schedule; Humans; Osteitis Deformans; Osteoclasts; Pamidronate;

1994
Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone.
    Drugs & aging, 1998, Volume: 12, Issue:2

    Topics: Antineoplastic Agents; Bone Neoplasms; Bone Resorption; Diphosphonates; Humans; Hypercalcemia; Neopl

1998
Pamidronate in the treatment of Paget's disease.
    Bone, 1999, Volume: 24, Issue:5 Suppl

    Topics: Anti-Inflammatory Agents; Diphosphonates; Humans; Osteitis Deformans; Pamidronate

1999
Pamidronate.
    The Annals of pharmacotherapy, 1992, Volume: 26, Issue:10

    Topics: Bone Neoplasms; Clinical Trials as Topic; Diphosphonates; Humans; Hypercalcemia; Osteitis Deformans;

1992
Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
    Drugs, 1991, Volume: 41, Issue:2

    Topics: Animals; Bone Resorption; Diphosphonates; Drug Evaluation; Humans; Hypercalcemia; Osteitis Deformans

1991
Dynamic radiologic patterns of Paget's disease of bone.
    Clinical orthopaedics and related research, 1987, Issue:217

    Topics: Biomechanical Phenomena; Bone and Bones; Bone Development; Bone Resorption; Calcitonin; Diphosphonat

1987
[Biphosphonate as a therapeutic drug--experimental studies and clinical application].
    Therapeutische Umschau. Revue therapeutique, 1985, Volume: 42, Issue:6

    Topics: Animals; Calcinosis; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Hyperpar

1985

Trials

27 trials available for pamidronate and Osseous Paget's Disease

ArticleYear
Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm nonpagetic cortical bone.
    Bone, 2003, Volume: 32, Issue:1

    Topics: Aged; Analysis of Variance; Bone Density; Bone Resorption; Diphosphonates; Female; Follow-Up Studies

2003
Bisphosphonate resistance in Paget's disease of bone.
    Arthritis and rheumatism, 2003, Volume: 48, Issue:8

    Topics: Aged; Aged, 80 and over; Alendronate; Alkaline Phosphatase; Anti-Inflammatory Agents; Clodronic Acid

2003
Effect of bisphosphonate treatment in patients with Paget's disease of the skull.
    Rheumatology (Oxford, England), 2004, Volume: 43, Issue:1

    Topics: Aged; Aged, 80 and over; Audiometry; Diphosphonates; Female; Follow-Up Studies; Hearing Loss, Sensor

2004
A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
    Bone, 2004, Volume: 34, Issue:4

    Topics: Administration, Oral; Aged; Alendronate; Alkaline Phosphatase; Biomarkers; Bone and Bones; Calcium;

2004
The analgesic effect of pamidronate is not caused by the elevation of beta endorphin level in Paget's disease--a controlled pilot study.
    Neuro endocrinology letters, 2006, Volume: 27, Issue:4

    Topics: Aged; Analgesics; beta-Endorphin; Bone Density Conservation Agents; Diphosphonates; Female; Humans;

2006
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2007, Volume: 22, Issue:10

    Topics: Aged; Diphosphonates; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Hu

2007
Paget's disease of bone.
    British medical journal (Clinical research ed.), 1982, Jan-23, Volume: 284, Issue:6311

    Topics: Calcitonin; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate

1982
Comparison of methods of assessing response of Paget's disease to bisphosphonate therapy.
    Bone, 1995, Volume: 16, Issue:2

    Topics: Alkaline Phosphatase; Bone and Bones; Bone Remodeling; Diphosphonates; Follow-Up Studies; Half-Life;

1995
A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone.
    The Journal of rheumatology, 1994, Volume: 21, Issue:11

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Child; Creatinine; Diphosphonates; Female; Humans; Hy

1994
Effects of intravenous pamidronate therapy on Paget's disease of bone.
    The American journal of the medical sciences, 1994, Volume: 308, Issue:4

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium; Diphosphonates; Female; Humans; Hydroxyproli

1994
Preliminary study of multiple increasing oral doses of dimethyl-APD on bone metabolism dynamics and safety profile.
    Drugs under experimental and clinical research, 1994, Volume: 20, Issue:3

    Topics: Aged; Alkaline Phosphatase; Body Temperature; Bone and Bones; Calcium; Diphosphonates; Ergocalcifero

1994
Intravenous pamidronate: evolution of an effective treatment strategy.
    Seminars in arthritis and rheumatism, 1994, Volume: 23, Issue:4

    Topics: Aged; Alkaline Phosphatase; Diphosphonates; Drug Administration Schedule; Humans; Hydroxyproline; In

1994
Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
    Calcified tissue international, 1993, Volume: 53, Issue:4

    Topics: Alkaline Phosphatase; Calcitonin; Creatinine; Diphosphonates; Drug Administration Schedule; Drug Res

1993
[Bisphosphonate therapy of Paget's disease of bone with pamidronate].
    Medizinische Klinik (Munich, Germany : 1983), 1996, Jan-15, Volume: 91, Issue:1

    Topics: Aged; Bone Resorption; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedul

1996
Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1996, Volume: 11, Issue:8

    Topics: Aged; Aged, 80 and over; Amino Acids; Analysis of Variance; Biomarkers; Bone Remodeling; Cross-Linki

1996
Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
    Bone, 1996, Volume: 19, Issue:4

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Analysis of Variance; Bone and Bones; Diphosphonates;

1996
Pamidronate infusions for the treatment of Paget's disease of bone.
    Revue du rhumatisme (English ed.), 1996, Volume: 63, Issue:1

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Chi-Square Distribution; Diphosphonates; Dose-Respons

1996
Pamidronate and biochemical markers of bone turnover.
    Scandinavian journal of clinical and laboratory investigation, 1997, Volume: 57, Issue:7

    Topics: Acid Phosphatase; Adult; Aged; Amino Acids; Biomarkers; Bone and Bones; Bone Resorption; Calcitriol;

1997
Urinary free deoxypyridinoline by chemiluminescence immunoassay: analytical and clinical evaluation.
    Clinical chemistry, 1998, Volume: 44, Issue:10

    Topics: Adult; Amino Acids; Animals; Antibodies, Monoclonal; Biomarkers; Bone Diseases; Diphosphonates; Fema

1998
Evaluation of adverse experiences related to pamidronate infusion in Paget's disease of bone.
    Annals of the rheumatic diseases, 1998, Volume: 57, Issue:9

    Topics: Aged; Anti-Inflammatory Agents; Diphosphonates; Double-Blind Method; Female; Fever; Headache; Humans

1998
Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodium.
    Bone, 1999, Volume: 24, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Bone Density; Calcitriol; Calcium, Dietary; Diphospho

1999
Paget's disease: acquired resistance to one aminobisphosphonate with retained response to another.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1999, Volume: 14 Suppl 2

    Topics: Aged; Alendronate; Diphosphonates; Drug Resistance; Female; Humans; Male; Osteitis Deformans; Pamidr

1999
Effect of multiple intravenous pamidronate courses in Paget's disease of bone.
    Revue du rhumatisme (English ed.), 1999, Volume: 66, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bone Demineralization, Pathologic; Diphosp

1999
Pamidronate.
    The Annals of pharmacotherapy, 1992, Volume: 26, Issue:10

    Topics: Bone Neoplasms; Clinical Trials as Topic; Diphosphonates; Humans; Hypercalcemia; Osteitis Deformans;

1992
Clinical experience with pamidronate in the treatment of Paget's disease of bone.
    Annals of the rheumatic diseases, 1991, Volume: 50, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Creatinine; Diphosphonates; Dose-Response Rela

1991
Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
    Clinical orthopaedics and related research, 1987, Issue:217

    Topics: Administration, Oral; Alkaline Phosphatase; Biopsy; Bone and Bones; Clinical Trials as Topic; Clodro

1987
Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.
    Annals of the rheumatic diseases, 1985, Volume: 44, Issue:1

    Topics: Aged; Alkaline Phosphatase; Clinical Trials as Topic; Creatinine; Diphosphonates; Etidronic Acid; Hu

1985

Other Studies

132 other studies available for pamidronate and Osseous Paget's Disease

ArticleYear
Updates on Paget's Disease of Bone.
    Endocrinology and metabolism (Seoul, Korea), 2022, Volume: 37, Issue:5

    Topics: Bone and Bones; Bone Resorption; Diphosphonates; Humans; Osteitis Deformans; Pamidronate

2022
Rhizomelia and Impaired Linear Growth in a Girl with Juvenile Paget Disease: The Natural History of the Condition.
    Hormone research in paediatrics, 2021, Volume: 94, Issue:3-4

    Topics: Adolescent; Child; Child, Preschool; Denosumab; Female; Femur; Growth Plate; Humans; Humerus; Osteit

2021
Acquired resistance to pamidronate treated effectively with zoledronate in juvenile Paget's disease.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2018, Volume: 29, Issue:6

    Topics: Bone Density Conservation Agents; Drug Resistance; Drug Substitution; Gene Deletion; Humans; Infant;

2018
Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK.
    Bone, 2014, Volume: 68

    Topics: Adolescent; Amino Acid Sequence; Base Sequence; Child; Child, Preschool; Dentition; Diphosphonates;

2014
Paget's disease of bone and osteonecrosis.
    Dental update, 2009, Volume: 36, Issue:3

    Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Dry Socket; Female; Humans; Hypercementosis;

2009
[Paget's disease and hypercalcemia: coincidence or causal relationship?].
    Harefuah, 2009, Volume: 148, Issue:10

    Topics: Aged; Anti-Inflammatory Agents; Diphosphonates; Female; Fractures, Bone; Humans; Hypercalcemia; Oste

2009
Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2013, Volume: 28, Issue:6

    Topics: Adult; Amino Acid Substitution; Bone Density Conservation Agents; Child, Preschool; Craniosynostoses

2013
Successful treatment of optic neuropathy in osteitis deformans.
    Rheumatology (Oxford, England), 2002, Volume: 41, Issue:8

    Topics: Aged; Anti-Inflammatory Agents; Dexamethasone; Diphosphonates; Drug Therapy, Combination; Humans; Ma

2002
Investigation of bone disease using isomerized and racemized fragments of type I collagen.
    Calcified tissue international, 2003, Volume: 72, Issue:1

    Topics: Adult; Aged; Biomarkers; Bone Diseases; Bone Neoplasms; Bone Resorption; Cells, Cultured; Collagen;

2003
[Fibrous dysplasia: differential diagnosis from Paget's disease].
    Deutsche medizinische Wochenschrift (1946), 2002, Oct-25, Volume: 127, Issue:43

    Topics: Absorptiometry, Photon; Adult; Anti-Inflammatory Agents; Biopsy; Bone Diseases, Metabolic; Diagnosis

2002
Magnetic resonance imaging presentation of lytic Paget's disease of the cervical spine.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2002, Volume: 17, Issue:11

    Topics: Aged; Alkaline Phosphatase; Cervical Vertebrae; Diphosphonates; Humans; Magnetic Resonance Imaging;

2002
Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate.
    Bone, 2003, Volume: 32, Issue:1

    Topics: Aged; Analysis of Variance; Cholesterol, HDL; Cholesterol, LDL; Diphosphonates; Female; Humans; Infu

2003
The renal clearance of free and peptide-bound deoxypyridinoline: response to pamidronate treatment of Paget's disease.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2003, Volume: 18, Issue:4

    Topics: Aged; Aged, 80 and over; Amino Acids; Collagen; Cross-Linking Reagents; Diphosphonates; Female; Huma

2003
Patterns of pain in Paget's disease of bone and their outcomes on treatment with pamidronate.
    Clinical rheumatology, 2003, Volume: 22, Issue:6

    Topics: Aged; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow

2003
Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
    Calcified tissue international, 2004, Volume: 75, Issue:3

    Topics: Administration, Oral; Alkaline Phosphatase; Calcitriol; Clodronic Acid; Diphosphonates; Drug Toleran

2004
Chronic idiopathic hyperphosphatasia: normalization of bone turnover with cyclical intravenous pamidronate therapy.
    Bone, 2004, Volume: 35, Issue:1

    Topics: Administration, Oral; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Remodeling; Child; Diph

2004
The treatment of Paget's disease.
    Rheumatology (Oxford, England), 2005, Volume: 44, Issue:2

    Topics: Anti-Inflammatory Agents; Diphosphonates; Drug Administration Schedule; Humans; Osteitis Deformans;

2005
Paget's disease of bone.
    The Medical journal of Australia, 2005, Feb-07, Volume: 182, Issue:3

    Topics: Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Diphosphonates; Humans; Male; Osteitis Deforma

2005
Bisphosphonates and avascular necrosis of the jaw: a possible association.
    The Medical journal of Australia, 2005, Apr-18, Volume: 182, Issue:8

    Topics: Aged; Aged, 80 and over; Alendronate; Anti-Inflammatory Agents; Diphosphonates; Female; Follow-Up St

2005
Hearing loss treated with pamidronate.
    Journal of the Royal Society of Medicine, 2005, Volume: 98, Issue:6

    Topics: Aged; Anti-Inflammatory Agents; Audiometry; Child; Diphosphonates; Hearing Loss, Sensorineural; Huma

2005
Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
    Bone, 2007, Volume: 40, Issue:2

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Density Conservation Agents; Collagen Type I; Di

2007
Paget's disease of the bone: a report of three cases.
    The Journal of the Association of Physicians of India, 2006, Volume: 54

    Topics: Aged; Alkaline Phosphatase; Bone Density Conservation Agents; Chest Pain; Diphosphonates; Female; Hu

2006
Paget's disease and bisphosphonate-associated osteonecrosis of the jaws.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2008, Volume: 66, Issue:6

    Topics: Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Injections,

2008
Bisphosphonates and Paget's disease.
    Lancet (London, England), 1980, Jun-28, Volume: 1, Issue:8183

    Topics: Diphosphonates; Humans; Organophosphonates; Osteitis Deformans; Pamidronate; Propanolamines

1980
Treatment of Paget's bone disease with the bisphosphonate APD.
    Henry Ford Hospital medical journal, 1983, Volume: 31, Issue:4

    Topics: Aged; Alkaline Phosphatase; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Mi

1983
Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
    Australian and New Zealand journal of medicine, 1984, Volume: 14, Issue:6

    Topics: Aged; Alkaline Phosphatase; Calcitonin; Calcium; Diphosphonates; Drug Therapy, Combination; Etidroni

1984
APD in Paget's disease of bone. Role of the mononuclear phagocyte system?
    Arthritis and rheumatism, 1980, Volume: 23, Issue:10

    Topics: Animals; Arthritis, Rheumatoid; Calcitonin; Clodronic Acid; Diphosphonates; Drug Therapy, Combinatio

1980
Treatment of Paget's bone disease with a bisphosphonate.
    Medicina, 1984, Volume: 44, Issue:3

    Topics: Adult; Aged; Alkaline Phosphatase; Diphosphonates; Female; Humans; Male; Middle Aged; Osteitis Defor

1984
Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone.
    European journal of clinical investigation, 1982, Volume: 12, Issue:1

    Topics: Alkaline Phosphatase; Calcium; Diphosphonates; Fever; Humans; Hydroxyproline; Osteitis Deformans; Pa

1982
Regulation of calcium absorption by 1,25,dihydroxy-vitamin D--studies of the effects of a bisphosphonate treatment.
    Calcified tissue international, 1982, Volume: 34, Issue:4

    Topics: Aged; Bone Resorption; Calcitriol; Calcium; Diphosphonates; Humans; Hypocalcemia; Middle Aged; Ostei

1982
Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium.
    Calcified tissue international, 1982, Volume: 34, Issue:4

    Topics: Adult; Aged; Bone Resorption; Calcium; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyro

1982
Quantitative bone scintigraphy in the management of monostotic Paget's disease of bone.
    Arthritis and rheumatism, 1995, Volume: 38, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Bone Remodeling; Diphosphonates; Female; Humans; Male; Middle Aged;

1995
Lymphocyte subsets in pamidronate-induced lymphopenia.
    British journal of rheumatology, 1995, Volume: 34, Issue:10

    Topics: Diphosphonates; Humans; Lymphocyte Subsets; Lymphopenia; Osteitis Deformans; Pamidronate

1995
Treatment of Paget's disease of bone with bisphosphonates.
    Revue du rhumatisme (English ed.), 1995, Volume: 62, Issue:2

    Topics: Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate

1995
Intravenous aminohydroxypropylidene bisphosphonate does not modify 99mTc-hydroxymethylene bisphosphonate bone scintigraphy. A prospective study.
    Revue du rhumatisme (English ed.), 1995, Volume: 62, Issue:2

    Topics: Aged; Bone Neoplasms; Diphosphonates; Female; Humans; Hypercalcemia; Infusions, Intravenous; Male; M

1995
Tracer flows and 'difficult' organs.
    Nuclear medicine communications, 1995, Volume: 16, Issue:1

    Topics: Bone and Bones; Diphosphonates; Etidronic Acid; Humans; Kidney; Kinetics; Models, Biological; Models

1995
Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1995, Volume: 10, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Bone Development; Chemical Fractionation; Chromatograph

1995
Ototoxicity associated with intravenous bisphosphonate administration.
    Calcified tissue international, 1995, Volume: 56, Issue:6

    Topics: Diphosphonates; Hearing Disorders; Humans; Injections, Intravenous; Male; Middle Aged; Osteitis Defo

1995
Pamidronate treatment of the neurologic sequelae of pagetic spinal stenosis.
    Archives of internal medicine, 1995, Sep-11, Volume: 155, Issue:16

    Topics: Aged; Aged, 80 and over; Diphosphonates; Humans; Male; Osteitis Deformans; Pamidronate; Peripheral N

1995
Pamidronate and uveitis.
    British journal of rheumatology, 1995, Volume: 34, Issue:5

    Topics: Diphosphonates; Female; Humans; Middle Aged; Osteitis Deformans; Pamidronate; Streptococcus pneumoni

1995
Monostotic Paget's disease involving the calcaneus. Diagnostic and therapeutic problems. Two case-reports.
    Revue du rhumatisme (English ed.), 1995, Volume: 62, Issue:1

    Topics: Calcaneus; Diphosphonates; Female; Humans; Male; Middle Aged; Osteitis Deformans; Pamidronate; Tomog

1995
Extensive personal experience: Paget's disease of bone.
    The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:2

    Topics: Animals; Calcitonin; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pain; Pamidronate;

1995
Oral pamidronate in refractory Paget's disease.
    Calcified tissue international, 1994, Volume: 55, Issue:3

    Topics: Administration, Oral; Diphosphonates; Humans; Osteitis Deformans; Pamidronate

1994
Hemifacial spasm and osteitis deformans.
    American journal of ophthalmology, 1995, Volume: 119, Issue:3

    Topics: Aged; Botulinum Toxins; Diphosphonates; Facial Bones; Facial Muscles; Female; Humans; Magnetic Reson

1995
Mineralisation defects with pamidronate therapy for Paget's disease.
    Lancet (London, England), 1993, Dec-11, Volume: 342, Issue:8885

    Topics: Calcification, Physiologic; Diphosphonates; Female; Humans; Male; Osteitis Deformans; Osteomalacia;

1993
Pamidronate and Paget's disease.
    Lancet (London, England), 1994, Feb-12, Volume: 343, Issue:8894

    Topics: Calcification, Physiologic; Diphosphonates; Humans; Osteitis Deformans; Pamidronate

1994
Osteomalacia after pamidronate for Paget's disease.
    Lancet (London, England), 1994, Apr-02, Volume: 343, Issue:8901

    Topics: Diphosphonates; Humans; Osteitis Deformans; Osteomalacia; Pamidronate

1994
Mineralisation defects after pamidronate for Paget's disease.
    Lancet (London, England), 1994, May-14, Volume: 343, Issue:8907

    Topics: Calcification, Physiologic; Diphosphonates; Humans; Hyperparathyroidism, Secondary; Osteitis Deforma

1994
Uveitis associated with pamidronate.
    Australian and New Zealand journal of medicine, 1994, Volume: 24, Issue:3

    Topics: Diphosphonates; Humans; Male; Middle Aged; Osteitis Deformans; Pamidronate; Uveitis; Uveitis, Anteri

1994
Response of biochemical markers of bone turnover to pamidronate infusion in Paget's disease of bone.
    Seminars in arthritis and rheumatism, 1994, Volume: 23, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Collagen; Diphosphonates; Female;

1994
Dramatic response to plicamycin in a patient with severe Paget's disease refractory to calcitonin and pamidronate.
    Seminars in arthritis and rheumatism, 1994, Volume: 23, Issue:4

    Topics: Aged; Aged, 80 and over; Calcitonin; Diphosphonates; Female; Humans; Osteitis Deformans; Pamidronate

1994
Single-day intravenous pamidronate in Paget's disease.
    Seminars in arthritis and rheumatism, 1994, Volume: 23, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Dose-Response Relationship, Dr

1994
Use of the bisphosphonate space in treatment and retreatment of Paget's disease.
    Seminars in arthritis and rheumatism, 1994, Volume: 23, Issue:4

    Topics: Alkaline Phosphatase; Diphosphonates; Humans; Osteitis Deformans; Pamidronate; Remission Induction

1994
Moderate Paget's disease treated with pamidronate: comparison of various infusion rates for a 60-mg single dose.
    Seminars in arthritis and rheumatism, 1994, Volume: 23, Issue:4

    Topics: Diphosphonates; Drug Administration Schedule; Feasibility Studies; Humans; Infusions, Intravenous; O

1994
Response of 99mTc-MDP scanning and whole-body retention to intravenous pamidronate.
    Seminars in arthritis and rheumatism, 1994, Volume: 23, Issue:4

    Topics: Aged; Diphosphonates; Female; Humans; Male; Middle Aged; Osteitis Deformans; Pamidronate; Radionucli

1994
Treatment of Paget's disease of bone with single-dose intravenous pamidronate.
    Seminars in arthritis and rheumatism, 1994, Volume: 23, Issue:4

    Topics: Delayed-Action Preparations; Diphosphonates; Humans; Infusions, Intravenous; Osteitis Deformans; Pam

1994
Long-term efficacy of intravenous pamidronate in Paget's disease of bone.
    Seminars in arthritis and rheumatism, 1994, Volume: 23, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Drug Administration Schedule;

1994
Intravenous aminopropylidene bisphosphonate in the treatment of severe polyostotic Paget's disease of bone.
    Seminars in arthritis and rheumatism, 1994, Volume: 23, Issue:4

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Female; Humans; Hydroxyproline; Infus

1994
Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity.
    Seminars in arthritis and rheumatism, 1994, Volume: 23, Issue:4

    Topics: Alkaline Phosphatase; Diphosphonates; Dose-Response Relationship, Drug; Humans; Hydroxyproline; Infu

1994
Effect of pamidronate on indices of bone turnover in Paget's disease followed for 6 years.
    Seminars in arthritis and rheumatism, 1994, Volume: 23, Issue:4

    Topics: Aged; Bone Remodeling; Diphosphonates; Female; Follow-Up Studies; Humans; Male; Middle Aged; Osteiti

1994
Pamidronate disodium and possible ocular adverse drug reactions.
    American journal of ophthalmology, 1994, Aug-15, Volume: 118, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Conjunctivitis; Diphosphonates; Drug Hypersensitivity; H

1994
Long-term elevation of 1,25-dihydroxyvitamin D after short-term intravenous administration of pamidronate (aminohydroxypropylidene bisphosphonate, APD) in Paget's disease of bone.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1994, Volume: 9, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Resorption; Calcitriol; Calcium; Diphosphonates; Fe

1994
Paget's disease--five years follow up after pamidronate therapy.
    British journal of rheumatology, 1994, Volume: 33, Issue:1

    Topics: Aged; Diphosphonates; Follow-Up Studies; Humans; Male; Osteitis Deformans; Pamidronate

1994
Paget's disease of bone: five regimens of pamidronate treatment.
    Clinical rheumatology, 1994, Volume: 13, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Drug Adm

1994
Treatment of Paget's disease of bone with single dose intravenous pamidronate.
    Annals of the rheumatic diseases, 1993, Volume: 52, Issue:8

    Topics: Aged; Alkaline Phosphatase; Diphosphonates; Female; Humans; Infusions, Intravenous; Male; Middle Age

1993
Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone?
    Bone and mineral, 1993, Volume: 22, Issue:1

    Topics: Amino Acids; Biomarkers; Bone Resorption; Calcitonin; Chromatography, High Pressure Liquid; Diphosph

1993
Prevalence of canine distemper antibodies in the pagetic population.
    Journal of medical virology, 1993, Volume: 40, Issue:4

    Topics: Adult; Antibodies, Viral; Bone and Bones; Diphosphonates; Distemper Virus, Canine; Humans; In Situ H

1993
Determinants of remission of Paget's disease of bone.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1993, Volume: 8, Issue:12

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bone and Bones; Diphosphonates; Female; Humans; Hydro

1993
Effects of intravenous aminopropylidene bisphosphonate in patients with refractory Paget's disease.
    British journal of rheumatology, 1993, Volume: 32, Issue:8

    Topics: Aged; Alkaline Phosphatase; Diphosphonates; Female; Humans; Injections, Intravenous; Male; Middle Ag

1993
[Paget's disease of bone and treatment with pamidronate].
    Vnitrni lekarstvi, 1993, Volume: 39, Issue:7

    Topics: Aged; Diphosphonates; Female; Humans; Male; Middle Aged; Osteitis Deformans; Pamidronate

1993
Extracellular protein secretion of cultured normal and Pagetic osteoblasts.
    Electrophoresis, 1993, Volume: 14, Issue:7

    Topics: Aged; Alkaline Phosphatase; Blotting, Western; Cells, Cultured; Collagen; Cyclic AMP; Dinoprostone;

1993
Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1993, Volume: 8, Issue:2

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bone Resorption; Diphosphonates; Drug Administ

1993
Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1993, Volume: 8, Issue:2

    Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Density; Data Interpreta

1993
[Concerning:"Moderate Paget's disease treated with pamidronate (ADP): experience in 43 patients with a single 60 mg perfusion of various duration of 1-to-24 hours" by D. Thièbaud at al. (Schweiz. med. Wschr. 1992; 122:1889-1894)].
    Schweizerische medizinische Wochenschrift, 1993, Mar-27, Volume: 123, Issue:12

    Topics: Diphosphonates; Humans; Infusions, Parenteral; Osteitis Deformans; Pamidronate

1993
Therapeutic strategy in Paget's disease of bone.
    Bone, 1995, Volume: 17, Issue:5 Suppl

    Topics: Administration, Oral; Adult; Aged; Alkaline Phosphatase; Analgesics, Non-Narcotic; Biomarkers; Bone

1995
Disodium pamidronate has beneficial effect in Paget's disease of bone.
    BMJ (Clinical research ed.), 1996, Jun-08, Volume: 312, Issue:7044

    Topics: Diphosphonates; Humans; Osteitis Deformans; Pamidronate

1996
Iritis following intravenous pamidronate.
    Australian and New Zealand journal of medicine, 1996, Volume: 26, Issue:3

    Topics: Aged; Diphosphonates; Female; Humans; Hypercalcemia; Iritis; Male; Middle Aged; Osteitis Deformans;

1996
High-dose pamidronate in the management of resistant Paget's disease.
    Calcified tissue international, 1996, Volume: 58, Issue:1

    Topics: Aged; Alkaline Phosphatase; Bone Resorption; Diphosphonates; Dose-Response Relationship, Drug; Femal

1996
Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1997, Volume: 12, Issue:7

    Topics: Adult; Alendronate; Amino Acid Sequence; Antibodies; Biomarkers; Bone Resorption; Collagen; Collagen

1997
Treatment of Paget's disease of bone with intravenous pamidronate: comparison of 2 different modes of treatment.
    The Journal of rheumatology, 1997, Volume: 24, Issue:11

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Disease-Free Survival; Female; Humans

1997
Three phase 99Tcm (V)DMSA scintigraphy in Paget's disease: an indicator of pamidronate effect.
    The British journal of radiology, 1997, Volume: 70, Issue:838

    Topics: Aged; Aged, 80 and over; Diphosphonates; Humans; Humerus; Male; Osteitis Deformans; Pamidronate; Rad

1997
[Is beta 2-microglobulin a marker of bone remodeling in Paget's disease of bone?].
    Casopis lekaru ceskych, 1997, Dec-03, Volume: 136, Issue:23

    Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; beta 2-Microglobulin; Biomarkers; Bone Remodel

1997
[Treatment of Paget's disease with olpadronate. Its efficacy in partial responders to oral pamidronate].
    Medicina, 1997, Volume: 57 Suppl 1

    Topics: Aged; Diphosphonates; Drug Tolerance; Female; Humans; Male; Osteitis Deformans; Pamidronate; Retrosp

1997
Paget's disease in a vertebral body: sixteen years of evolution in a young patient.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1998, Volume: 13, Issue:9

    Topics: Administration, Oral; Adult; Biomarkers; Bone Density; Calcium; Diphosphonates; Female; Humans; Lumb

1998
Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase.
    Clinical chemistry, 1998, Volume: 44, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone and Bones; Bone Diseases; Bon

1998
[An attempt to treat loosening of the total hip endoprosthesis in Paget disease with Aredia].
    Chirurgia narzadow ruchu i ortopedia polska, 1998, Volume: 63, Issue:6

    Topics: Aged; Anti-Inflammatory Agents; Arthroplasty, Replacement, Hip; Diphosphonates; Female; Humans; Oste

1998
Measurement of bone mineral density by dual X-ray absorptiometry in Paget's disease before and after pamidronate treatment.
    Calcified tissue international, 1999, Volume: 65, Issue:3

    Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bone and Bones; Bone Dens

1999
Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease.
    Skeletal radiology, 2000, Volume: 29, Issue:5

    Topics: Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Arthralgia; Diphosphonates; Etidronic Acid; Fo

2000
Case of an ivory vertebra.
    Journal of endocrinological investigation, 2000, Volume: 23, Issue:8

    Topics: Alendronate; Alkaline Phosphatase; Biopsy; Bone Marrow; Carcinoid Tumor; Diagnosis, Differential; Di

2000
Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2001, Volume: 16, Issue:9

    Topics: Alendronate; Calcitriol; Calcium; Cervical Vertebrae; Diphosphonates; Female; Humans; Hypocalcemia;

2001
The use of a whole body index with bone scintigraphy to monitor the response to therapy in Paget's disease.
    Nuclear medicine communications, 2001, Volume: 22, Issue:10

    Topics: Aged; Aged, 80 and over; Algorithms; Alkaline Phosphatase; Anti-Inflammatory Agents, Non-Steroidal;

2001
[Paget disease or fibrous dysplasia of the radius?--A case report].
    Wiener medizinische Wochenschrift (1946), 2001, Volume: 151, Issue:13-14

    Topics: Diagnosis, Differential; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Sched

2001
Treatment of Paget's disease by weekly infusions of 3-aminohydroxypropylidene-1,1-bisphosphonate (APD).
    British journal of rheumatology, 1992, Volume: 31, Issue:2

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Creatinine; Diphosphonates; Drug Administration Sched

1992
Familial idiopathic hyperphosphatasia (FIH): response to long-term treatment with pamidronate (APD).
    Bone and mineral, 1992, Volume: 19, Issue:2

    Topics: Administration, Oral; Alkaline Phosphatase; Calcium; Calcium Gluconate; Child, Preschool; Diphosphon

1992
Paget's disease with osteolytic lesions: combining medical and surgical treatments.
    The Netherlands journal of medicine, 1992, Volume: 40, Issue:5-6

    Topics: Combined Modality Therapy; Diphosphonates; Femur; Humans; Hyperparathyroidism; Male; Middle Aged; Os

1992
[Moderate Paget's disease treated with pamidronate (APD): experience in 43 patients with a single 60 mg infusion of varying duration of 1-to-24 hours].
    Schweizerische medizinische Wochenschrift, 1992, Dec-05, Volume: 122, Issue:49

    Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Ambulatory Care; Creatinine; Diphosphonates; F

1992
Bone scintigraphy following intravenous pamidronate for Paget's disease of bone.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992, Volume: 33, Issue:9

    Topics: Alkaline Phosphatase; Creatinine; Diphosphonates; Humans; Hydroxyproline; Infusions, Intravenous; Os

1992
Pamidronate associated hallucinations.
    Annals of the rheumatic diseases, 1992, Volume: 51, Issue:7

    Topics: Aged; Diphosphonates; Hallucinations; Humans; Male; Osteitis Deformans; Pamidronate

1992
Pamidronate.
    The Medical letter on drugs and therapeutics, 1992, Jan-10, Volume: 34, Issue:861

    Topics: Clinical Trials as Topic; Diphosphonates; Humans; Hypercalcemia; Hyperparathyroidism; Neoplasms; Ost

1992
[Amino-hydroxy-propane diphosphonate (APD): satisfactory therapeutic response in a patient with Paget's disease of bone].
    Revista clinica espanola, 1991, Volume: 188, Issue:7

    Topics: Diphosphonates; Female; Humans; Middle Aged; Osteitis Deformans; Pamidronate

1991
Single-dose intravenous pamidronate is effective alternative therapy for Paget's disease refractory to calcitonin.
    Hormone research, 1991, Volume: 36, Issue:1-2

    Topics: Aged; Calcitonin; Calcium; Diphosphonates; Drug Resistance; Female; Humans; Hyperparathyroidism, Sec

1991
Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
    Bone and mineral, 1991, Volume: 12, Issue:2

    Topics: Aged; Calcium; Cyclic AMP; Diphosphonates; Female; Glomerular Filtration Rate; Humans; Hypercalcemia

1991
[Therapy of Paget's disease with bisphosphonate pamidronate (AHPrBP, formerly APD)].
    Klinische Wochenschrift, 1991, Jan-04, Volume: 69, Issue:1

    Topics: Aged; Alkaline Phosphatase; Bone and Bones; Bone Density; Diphosphonates; Female; Follow-Up Studies;

1991
Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses.
    Clinical endocrinology, 1991, Volume: 34, Issue:3

    Topics: Adult; Aged; Bone and Bones; Diphosphonates; Drug Administration Schedule; Female; Humans; Hydroxypr

1991
Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate (APD).
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1990, Volume: 5, Issue:12

    Topics: Alkaline Phosphatase; Calcium; Diphosphonates; Drug Administration Schedule; Follow-Up Studies; Huma

1990
Serial bone scans in Paget's disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment.
    Nuclear medicine communications, 1990, Volume: 11, Issue:11

    Topics: Aged; Aged, 80 and over; Diphosphonates; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteitis

1990
[Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
    Revue du rhumatisme et des maladies osteo-articulaires, 1989, Mar-15, Volume: 56, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcitonin; Diphosphonates; Drug Administratio

1989
'Breaking the back' of Paget's bone disease.
    Archives of internal medicine, 1989, Volume: 149, Issue:12

    Topics: Calcitonin; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate; Plicamycin

1989
Successful treatment of resistant Paget's disease of bone with pamidronate.
    Archives of internal medicine, 1989, Volume: 149, Issue:12

    Topics: Adult; Alkaline Phosphatase; Animals; Calcitonin; Diphosphonates; Drug Resistance; Humans; Male; Ost

1989
[Treatment of Paget's disease with AHPrBP].
    Revista clinica espanola, 1989, Volume: 185, Issue:9

    Topics: Diphosphonates; Drug Evaluation; Humans; Osteitis Deformans; Pamidronate

1989
[A single infusion of Pamidronate (APD) in Paget's disease of bone].
    Schweizerische medizinische Wochenschrift, 1989, Jan-21, Volume: 119, Issue:3

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Resorption; Diphosphonates; Female; Humans; Hydr

1989
Assay of 1-hydroxy-3-aminopropylidene-1,1-bisphosphonate and related bisphosphonates in human urine and plasma by high-performance ion chromatography.
    Journal of chromatography, 1989, May-30, Volume: 490, Issue:2

    Topics: Chromatography, High Pressure Liquid; Diphosphonates; Humans; Osteitis Deformans; Pamidronate; Phosp

1989
Pamidronate sodium and calcitonin-resistant Paget's disease. Immediate response in a patient.
    Archives of internal medicine, 1989, Volume: 149, Issue:2

    Topics: Alkaline Phosphatase; Calcitonin; Calcium; Calcium-Binding Proteins; Diphosphonates; Humans; Hydroxy

1989
Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphosphonate.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1989, Volume: 4, Issue:5

    Topics: Administration, Oral; Aged; Animals; Bone and Bones; Bone Resorption; Clinical Protocols; Diphosphon

1989
New drugs for Paget's disease.
    Lancet (London, England), 1986, Jun-21, Volume: 1, Issue:8495

    Topics: Calcitonin; Diphosphonates; Humans; Osteitis Deformans; Pamidronate

1986
Treating Paget's disease.
    British medical journal (Clinical research ed.), 1987, Jun-06, Volume: 294, Issue:6585

    Topics: Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate

1987
Radiological assessment of Paget's disease of bone after treatment with the bisphosphonates EHDP and APD.
    The British journal of radiology, 1987, Volume: 60, Issue:717

    Topics: Aged; Diphosphonates; Etidronic Acid; Female; Femur; Humans; Male; Middle Aged; Osteitis Deformans;

1987
Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).
    British medical journal (Clinical research ed.), 1987, Nov-21, Volume: 295, Issue:6609

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Body Temperature; Diphos

1987
Treatment of Paget's disease of bone.
    British medical journal (Clinical research ed.), 1988, Jan-23, Volume: 296, Issue:6617

    Topics: Aged; Diphosphonates; Humans; Infusions, Intravenous; Osteitis Deformans; Pamidronate

1988
Diphosphonates for otospongiosis.
    The American journal of otology, 1985, Volume: 6, Issue:1

    Topics: Adult; Bone Development; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Ma

1985
Relapse of osteoporosis circumscripta as a lytic ring after treatment of Paget's disease with intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate.
    The British journal of radiology, 1988, Volume: 61, Issue:731

    Topics: Adult; Diphosphonates; Female; Humans; Injections, Intravenous; Osteitis Deformans; Osteoporosis; Pa

1988
A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone.
    The American journal of medicine, 1988, Volume: 85, Issue:2

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium-Binding Proteins; Diphosphonates; Drug Admini

1988
Paget's disease of bone treated in five days with AHPrBP (APD) per Os.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1987, Volume: 2, Issue:1

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Female; Humans; Hydroxyproline; Male;

1987
Intravenous aminopropylidene bisphosphonate (APD) in the treatment of Paget's bone disease.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1987, Volume: 2, Issue:4

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium; Diphosphonates; Female; Humans; Infusions, I

1987
Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatment.
    The Journal of clinical endocrinology and metabolism, 1987, Volume: 65, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium-Binding Proteins; Diphosphonates; Fema

1987
Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD.
    Bone and mineral, 1986, Volume: 1, Issue:1

    Topics: Calcium; Diphosphonates; Humans; Hypercalcemia; Osteitis Deformans; Pamidronate; Parathyroid Hormone

1986
[Paget's disease of bone treated with APD in 5 days].
    Schweizerische medizinische Wochenschrift, 1987, May-09, Volume: 117, Issue:19

    Topics: Aged; Diphosphonates; Humans; Middle Aged; Osteitis Deformans; Pamidronate

1987
[Paget's disease of bone treated per os with APD in 5 days].
    Schweizerische medizinische Wochenschrift, 1986, Dec-13, Volume: 116, Issue:50

    Topics: Administration, Oral; Aged; Aged, 80 and over; Diphosphonates; Drug Evaluation; Female; Humans; Male

1986
Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.
    Annals of the rheumatic diseases, 1986, Volume: 45, Issue:12

    Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Female; Humans; Infusions, Intravenou

1986
Radiological demonstration of healing in Paget's disease of bone treated with APD.
    The British journal of radiology, 1985, Volume: 58, Issue:693

    Topics: Aged; Diphosphonates; Follow-Up Studies; Humans; Middle Aged; Osteitis Deformans; Pamidronate; Radio

1985
Quantitative bone scintigraphy in Paget's disease treated with APD.
    The British journal of radiology, 1985, Volume: 58, Issue:696

    Topics: Diphosphonates; Follow-Up Studies; Humans; Osteitis Deformans; Pamidronate; Radionuclide Imaging; Re

1985
Efficacy of the bisphosphonate APD in the control of Paget's bone disease.
    Bone, 1985, Volume: 6, Issue:6

    Topics: Adult; Aged; Alkaline Phosphatase; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged

1985